The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
This is interesting.
Can't recall a RNS making a point 'to investors" like the final paragraph in the RNS.
Maybe faron team are noticing we need more info to stay motivated investing here?
Analysts at Peel Hunt have reiterated their 'buy' rating and 524p price target
https://www.proactiveinvestors.co.uk/companies/news/995720/faron-pharma-gets-reiterated-buy-rating-from-peel-hunt-following-bexmarilimab-therapy-news-995720.html
https://twitter.com/FaronPharm/status/1583095162644746240?t=ckFlNmdB4d0EKvyRRYq4Yw&s=19
That gives you confidence
Thanks sax
Covgaz
Timo has been investing for years. And he keeps adding in millions.. he is no fool!
Timo is a believer..
Flow the money as they say :)
Just watched the proactive thing.. yes marku did seem agitated.
May be cause this was ghis 4th appointment and being up since 2 am
It was funny how he went off script about Finland able to defeat a Russian attack.
The markets seem to if annoyed him, and rightly so. We all know that putins personal war is doing everyone in!
Jonathan-knowles, "if you think PD1 was big, bex it's going to be bigger!"
Dobt forget that
https://www.faron.com/media/videos
I think this is the finish version of the recent presentation in Finnish.
Wo during if any of our Finnish friends here have watched it and if there are anything else marku says that's different from the English version?
https://www.labiotech.eu/trends-news/biopharma-company-faron-announces-escalation-data-cancer-treatment-study/
I think one lesson learned from traumakine is phase 3 trials need more data. They fell at this last hurdle cause o es receiving tramakine where also on steroids which nullified the treatment.
Finding out who bex will work on and who not I key to getting 100% success rate in phase 3 trials and that's what they have done.
It's looking good guys
"Just to be clear!"
They answered one of my questions, bexcombo, who what drug and when
Didn't catch the full answer :)
Merck – the manufacturer of Keytruda (pembrolizumab)
Confirmed that's who they will be partying with for bexcombo.. or at least its Merck drug they will combo with.
Could they be a possible financial partner?
Mercy as a poss
Who did they say they had a very good relationship with in the US... Anderson something?
Jonathan Knowles is very confident that bex works.
Also he is impressed at the amount of information they have at this stage of trials
We can ask questions!
Google is now showing £2
Imagine being one of those end of line patients, exhusted all other options, probably chemo and radiated to half death, and then comes bex and 14.9 months later, you are still alive!
"Median overall survival based on patients from Part I and II (n=138) was 14.9 months for patients who benefited from treatment with bexmarilimab compared to 4.4 months for those who did not, representing a 3.4-fold increase"